BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16432833)

  • 21. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling non-random deletions in cancer.
    Kost-Alimova M; Imreh S
    Semin Cancer Biol; 2007 Feb; 17(1):19-30. PubMed ID: 17174104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
    Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
    J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mandatory chromosomal segment balance in aneuploid tumor cells.
    Kost-Alimova M; Darai-Ramqvist E; Yau WL; Sandlund A; Fedorova L; Yang Y; Kholodnyuk I; Cheng Y; Li Lung M; Stanbridge E; Klein G; Imreh S
    BMC Cancer; 2007 Jan; 7():21. PubMed ID: 17257397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of down-regulated expressed sequence tag at chromosome 3p21 in nasopharyngeal carcinoma].
    He XS; Chen ZC; Tian F; Xiao ZQ; He ZM; Guan YJ; Li F; He CM; Yuan JH
    Ai Zheng; 2003 Jan; 22(1):1-5. PubMed ID: 12561426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
    Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
    Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.
    Yi Lo PH; Chung Leung AC; Xiong W; Law S; Duh FM; Lerman MI; Stanbridge EJ; Lung ML
    Cancer Lett; 2006 Mar; 234(2):184-92. PubMed ID: 15885884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.
    Iijima H; Tomizawa Y; Iwasaki Y; Sato K; Sunaga N; Dobashi K; Saito R; Nakajima T; Minna JD; Mori M
    Int J Cancer; 2006 Feb; 118(4):797-801. PubMed ID: 16152584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer.
    Sikkink SK; Rehman I; Rees JL
    J Invest Dermatol; 1997 Dec; 109(6):801-5. PubMed ID: 9406824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR.
    Braga E; Senchenko V; Bazov I; Loginov W; Liu J; Ermilova V; Kazubskaya T; Garkavtseva R; Mazurenko N; Kisseljov F; Lerman MI; Klein G; Kisselev L; Zabarovsky ER
    Int J Cancer; 2002 Aug; 100(5):534-41. PubMed ID: 12124802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.